文献速递消化内镜消化道肿瘤与早癌

内镜黏膜下剥离术治疗结直肠黏膜下肿瘤的疗效与安全性

Efficacy and safety of endoscopic submucosal dissection for submucosal tumors of the colon and rectum.
PubMed 文献 · Gastrointest Endosc · 2017-10-04

回顾性分析2008年1月至2014年7月于复旦大学附属中山医院连续接受内镜黏膜下剥离术(ESD)的412例结直肠黏膜下肿瘤(SMT)患者,完全切除率86.9%,严重不良事件3.2%,术后电凝综合征6.8%;结肠部位、固有肌层起源及大小≥20 mm与不良事件风险升高相关。

要点

  • 结直肠SMT行ESD完全切除率为86.9%,严重不良事件率3.2%。
  • 结肠SMT不完全切除(19.6% vs 11.3%)、严重不良事件(8.7% vs 1.6%)及术后电凝综合征(16.3% vs 4.1%)风险高于直肠。
  • 固有肌层来源及大小≥20 mm的SMT术后电凝综合征发生率分别高于非固有肌层来源(22.7% vs 5.9%)和<20 mm者(31.3% vs 5.8%)。

核心结论

  • ESD可有效切除结直肠SMT,严重不良事件少见;肿瘤部位和内镜医师经验影响完全切除率和严重不良事件发生;ESD用于较大肿瘤和固有肌层肿瘤可行,但不良事件风险相对较高。

研究设计与样本

  • 回顾性研究,纳入2008年1月至2014年7月在复旦大学附属中山医院连续接受ESD的412例结直肠SMT患者,分析肿瘤组织病理、切除完整性、不良事件、肿瘤复发和远处转移。

主要发现

  • 358处病变(86.9%)实现完全切除。
  • 13例(3.2%)发生严重不良事件,包括出血和穿孔;28例(6.8%)发生ESD术后电凝综合征(PEECS)。
  • 随内镜医师实施结直肠SMT的ESD增多,完全切除率升高(78.5% vs 88.5%),严重不良事件率降低(9.2% vs 2.0%)。
  • 结肠SMT增加不完全切除风险(19.6% vs 11.3%)、严重不良事件风险(8.7% vs 1.6%)和PEECS风险(16.3% vs 4.1%)。
  • 固有肌层来源和大小≥20 mm的SMT分别增加PEECS发生率(22.7% vs 5.9%和31.3% vs 5.8%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) of colorectal submucosal tumors (SMTs) is becoming increasingly common; however, there have been few large consecutive studies analyzing its therapeutic efficacy and safety. The aim of this study was to evaluate the efficacy, safety, and long-term outcomes of ESD for colorectal SMTs. METHODS: This retrospective study included 412 consecutive patients with colorectal SMTs who underwent ESD at the Zhongshan Hospital of Fudan University from January 2008 to July 2014. Tumor histopathology, completeness of resection, adverse events, tumor recurrence, and distant metastasis were analyzed. RESULTS: Complete resection was achieved for 358 lesions (86.9%). Thirteen patients had serious adverse events (3.2%) including bleeding and perforation, and 28 patients (6.8%) had post-ESD electrocoagulation syndrome (PEECS). Because more ESDs for colorectal SMTs were performed by endoscopists, the rate of complete resection increased (78.5% vs 88.5%), and the rate of serious adverse events decreased (9.2% vs 2.0%). SMTs in the colon increased the risk of incomplete resection (19.6% vs 11.3%), serious adverse events (8.7% vs 1.6%), and PEECS (16.3% vs 4.1%). SMTs originating from the muscularis propria and sized ≥20 mm increased the rate of PEECS (22.7% vs 5.9% and 31.3% vs 5.8%, respectively). CONCLUSION: ESD is effective for resection of colorectal SMTs and rarely causes serious adverse events. Tumor location and the experience of endoscopists influence the complete resection rate and the development of serious adverse events. ESD is feasible for large tumors and tumors in the muscularis propria, but this is associated with relatively high risks of adverse events.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Qi ZP, Shi Q, Liu JZ, et al. Efficacy and safety of endoscopic submucosal dissection for submucosal tumors of the colon and rectum. Gastrointest Endosc. 2017. PMID: 28987548. doi:10.1016/j.gie.2017.09.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。